COVID-19 Therapeutics Mini-Toolkit

Resources for Nursing Home Residents and Families

• Don't Wait — Treat! (PDF), TMF QIN-QIO
• Information Sheet: Lagevrio (Molnupiravir) Eligibility and Effectiveness (PDF), Association for Strategic Preparedness and Response (ASPR)
• Information Sheet: Paxlovid Eligibility and Effectiveness (PDF), ASPR
• Veklury (remdesivir), ASPR
• Personal COVID-19 Plan (PDF), Centers for Disease Control and Prevention (CDC)

Resources for Nursing Home Staff and Leadership

• Coronavirus (COVID-19) Drugs, U.S. Food and Drug Administration (FDA)
• Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, National Institutes of Health (NIH)
• COVID-19 Outpatient Therapeutic Resources Digital Toolkit, ASPR
• COVID-19 Therapeutics Resources, ASPR
• COVID-19 Treatments and Medications, CDC
• Paxlovid Patient Eligibility Screening Checklist and Drug Interaction Tool for Prescribers (PDF), FDA
• Prescriber Checklist for Molnupiravir, (PDF), FDA
• Revised Statement on Evusheld, NIH
• Side-by-Side Overview of Therapeutics Authorized or Approved for the Treatment of Mild to Moderate COVID-19 (PDF), ASPR
• State Regulatory Landscape Reports, NICA

Additional Resources

• COVID-19 Therapeutics Fact Sheet (PDF), TMF Quality Innovation Network-Quality Improvement Organization (QIN-QIO)
• COVID-19 Therapeutics Locator, ASPR
• COVID-19 Vaccination and Therapeutics in PALTC Toolkit: Resources for Clinicians (PDF), AMDA-The Society for Post-Acute and Long-Term Care Medicine